A pilot open-label trial of minocycline in patients with autism and regressive features

被引：0
|
作者：
Carlos A Pardo
Ashura Buckley
Audrey Thurm
Li-Ching Lee
Arun Azhagiri
David M Neville
Susan E Swedo
机构：
[1] Johns Hopkins University School of Medicine,Department of Neurology, Pathology 627
[2] National Institute of Mental Health,Pediatrics & Developmental Neuroscience Branch
[3] Johns Hopkins University Bloomberg School of Public Health,Department of Epidemiology
来源：
Journal of Neurodevelopmental Disorders | 2013年 / 5卷
关键词：
Autism; Minocycline; Microglia; Neuroinflammation; Clinical trial; Cytokines; Chemokines; Metalloproteinases; Neurotrophins; BDNF;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Escitalopram in clinical practice: Results of an open-label trial in a naturalistic setting
    Rush, AJ
    Bose, A
    DEPRESSION AND ANXIETY, 2005, 21 (01) : 26 - 32
  • [32] A Prospective Open-Label Trial of Buspirone for the Treatment of Anxiety in Williams Syndrome
    Thom, Robyn P.
    Renzi, Danielle
    Pecukonis, Meredith
    Mullett, Jennifer
    Ravichandran, Caitlin
    Mcdougle, Christopher J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2024,
  • [33] Oral Human Immunoglobulin for Children with Autism and Gastrointestinal Dysfunction: A Prospective, Open-Label Study
    Cindy K. Schneider
    Raun D. Melmed
    Leon E. Barstow
    F. Javier Enriquez
    James Ranger-Moore
    James A. Ostrem
    Journal of Autism and Developmental Disorders, 2006, 36 : 1053 - 1064
  • [34] Oral human immunoglobulin for children with autism and gastrointestinal dysfunction: A prospective, open-label study
    Schneider, Cindy K.
    Melmed, Raun D.
    Enriquez, F. Javier
    Barstow, Leon E.
    Ranger-Moore, James
    Ostrem, James A.
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2006, 36 (08) : 1053 - 1064
  • [35] Clinical effectiveness and safety of escitalopram and desvenlafaxine in patients of depression with anxiety: A randomized, open-label controlled trial
    Maity, Nabakumar
    Ghosal, Malay Kumar
    Gupta, Anupam
    Sil, Amrita
    Chakraborty, Sushmita
    Chatterjee, Suparna
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 (04) : 433 - 437
  • [36] Successful Use of Minocycline for the Treatment of Methamphetamine-Induced Psychosis and Cognitive Impairments: An Open-Label Case Series
    Alavi, Sasan
    Darharaj, Mohammad
    Bilehsavar, Shirin Haghshenas
    Amini, Mahdi
    Zafarghandi, Mohammad Bagher Saberi
    Berenji, Vahid
    Arezoomandan, Reza
    CLINICAL NEUROPHARMACOLOGY, 2021, 44 (04) : 126 - 131
  • [37] Effectiveness of autoinoculation in viral warts: A single arm, open-label, and clinical trial
    Taneja, Gargi
    Hazarika, Neirita
    Bhatia, Riti
    DERMATOLOGIC THERAPY, 2020, 33 (06)
  • [38] PSILOCYBIN THERAPY FOR DEPRESSION AND ANXIETY IN PARKINSON'S DISEASE: AN OPEN-LABEL PILOT STUDY
    Bradley, Ellen
    Sakai, Kimberly
    Fernandes-Osterhold, Gisele
    Szigeti, Balazs
    Ludwig, Connie
    Ostrem, Jill
    Tanner, Caroline
    Bock, Meredith
    Llerena, Katiah
    Finley, Patrick
    O'Donovan, Aoife
    Zuzuarregui, Jose Rafael
    Busby, Zachary
    McKernan, Amber
    Penn, Andrew
    Wang, Aliss
    Rosen, Raymond
    Woolley, Joshua
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 : 407 - 408
  • [39] Ruxolitinib cream for discoid lupus erythematosus: An open-label pilot study of 10 subjects
    Bender, Alexandra M.
    Laageide, Leah
    Kaur, Japsimran
    Babkowski, Nicole
    Richardson, Christopher T.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2025, 92 (03) : 655 - 657
  • [40] Levetiracetam for cerebellar tremor in multiple sclerosis - An open-label pilot tolerability and efficacy study
    Striano, P
    Coppola, A
    Vacca, G
    Zara, F
    Morra, VB
    Orefice, G
    Striano, S
    JOURNAL OF NEUROLOGY, 2006, 253 (06) : 762 - 766
12345